$NDEV Achieves Higher Anticipated Results

 Novus Acquisition & Development Corp. (OTC PINK:NDEV) through its wholly owned Novus Medical Group subsidiary provides a healthcare program “Novus MedPlan,” offering a cost saving medical plan for patients within the medical marijuana arena (MMJ). Today the CEO Frank Labrozzi addresses the first 30 days of its digital marketing campaign.

Digital Marketing Campaign

Thirty days ago Novus MedPlan’s business model in the MMJ and integrative medicine sector began its test market in digital marketing in the State of Arizona. Novus utilized various companies such as Weedmaps, Marijuana.com and Mantis Network which have performed better than expected reaching and procuring patients in the test marketing effort, and additionally brought in dispensaries from many of the MMJ approved states to participate as providers.

Since the beginning of the test campaign 30 days ago in Arizona, total visits and impressions on the company site reached 255,873 views, and had a 4.2% Click Through Rate (CTR). For comparison, industry norm is around 2% CTR. As an added benefit of the marketing effort, 10 dispensaries have expressed interest in becoming Novus MedPlan Providers, facilitating entry into the Los Angeles and San Diego markets.

Despite internet policies limiting MMJ advertising, Novus MedPlan has managed to reach consumers and providers interested in participating in their healthcare program. Given the success of this digital marketing effort, management will be increasing the marketing budget three-fold and expanding the focus from Arizona to encompass Colorado, Oregon, Washington, Michigan and the much anticipated California, which could make up to 50% of the market share. Management is highly confident in their approach to ensure future dispensary and patient enrollment.

About Novus

Novus Acquisition & Development Corp. (“Novus”) provides health insurance and related insurance solutions to the wellness and medical marijuana industries in states where legal programs exist.

NDEV will work as outside developers and will not cultivate, handle, transport grow, extract, dispense put up for sale, put on the market, vend, deliver, supply, circulate, trade, cannabis or any substances that violates the United States law or the Controlled Substances Act, nor does it intend to do so in the future and will continue to follow state and federal laws. The products and statements made about specific products have not been evaluated by the United States Food and Drug Administration (FDA) and are not intended to diagnose, treat, cure or prevent disease. All information provided on these press releases or any information contained on or in any product label or packaging is for informational purposes only and is not intended as a substitute for advice from your physician or other health care professional. Once a push notification is competed the transaction is solely between the state licensed dispensary and the registered patient.

The state laws are in conflict with the federal Controlled Substances Act. The current administration has effectively stated that it is not an efficient use of resources to direct federal law enforcement agencies to prosecute those lawfully abiding by state designated laws allowing the use and distribution of medical marijuana. However, there is no guarantee that the current administration, nor any future administration, will not change this policy and decide to enforce the federal laws strongly. Any such change in the federal government’s enforcement of current federal laws could cause significant financial changes to the Company. While we do not intend to harvest, distribute or sell cannabis or cannabis related products, we may be harmed by a change in enforcement by federal or state governments.

Safe Harbor

This release includes forward-looking statements, which are based on certain assumptions and reflects management’s current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, includes codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.